Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5903987 | 6775703 | I | 5903987-0 | 20080101 | 20080918 | 20080930 | EXP | AU-ELI_LILLY_AND_COMPANY-AU200809004266 | ELI LILLY AND COMPANY | 42 | YR | F | Y | 20080926 | MD | AUSTRALIA |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
5903987 | 1010522465 | PS | ZYPREXA | 1 | ORAL | 15 MG, DAILY (1/D) | 020592 | ||||
5903987 | 1010522466 | C | ZOLOFT | 1 |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
5903987 | 1010522465 | BIPOLAR I DISORDER |
Outcome of event
Event ID | OUTC COD |
---|---|
5903987 | OT |
Reactions reported
Event ID | PT |
---|---|
5903987 | RETINAL DEGENERATION |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
5903987 | 1010522465 | 20070101 |